v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 3,484,514 $ 8,505,229 $ 5,894,089 $ 15,928,552
General and administrative 2,365,993 1,663,503 3,503,336 4,667,639
Loss from operations (5,850,507) (10,168,732) (9,397,425) (20,596,191)
Other income (expense):        
Interest income 400,257 872,038 963,235 1,853,525
Interest expense (23) (470,618) (468,702) (954,147)
Total other income, net 400,234 401,420 494,533 899,378
Net loss $ (5,450,273) $ (9,767,312) $ (8,902,892) $ (19,696,813)
Net loss per share - basic $ (0.09) $ (0.16) $ (0.15) $ (0.33)
Net loss per share - diluted $ (0.09) $ (0.16) $ (0.15) $ (0.33)
Weighted average common shares outstanding - basic 60,321,068 60,045,530 60,320,184 59,966,841
Weighted average common shares outstanding - diluted 60,321,068 60,045,530 60,320,184 59,966,841